Here is the updated 12-month forecast for Auris Medical Holding Ltd(EARS)

Market Data

Auris Medical Holding Ltd(EARS) is a stock of interest due to the large impact the company has on the market. Here at Wall Street Facts we only cover the best stocks so make sure you check out our other articles. Today we will be diving deep into all of the essential information you need to know about EARS. We will be studying the movement so you can make the best decision as an investor. The stock has moved downwards today by 1.75%. The high for today is 3.43 and today’s low is 3.35. This information is critical in deciding whether this investment is risky or not. We can see the stock is trending downwards, which means the volume of people selling this stock is greater than people buying it.

Company Description

Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through Switzerland and Australia geographical segments. Its product pipeline includes AM-125, AM-201, AM301, Sonsuvi, and Keyzilen. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.

Stock Forecast

As an investor, you can get an idea of where the stock is trending by the forecast. In this case, the high forecast for Auris Medical Holding Ltd is $15.53 and the low forecast is $9.37. Overall, Auris Medical Holding Ltd is in great shape going forward. They have a strong market cap of $43.37M and a very bright future ahead of them.

Leave a Reply

%d bloggers like this: